pyrroles has been researched along with Infarct in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brown, CE; Gerrow, K; Holmes, A; Lockhart, KL; Nahirney, PC; Reeson, P; Tennant, KA; Thompson, K; Wang, J; Weiser Novak, S | 1 |
Goldwasser, F; Mir, O; Ropert, S; Vignaux, O | 1 |
Gardner, DR; James, LF; Molyneux, RJ; Stegelmeier, BL | 1 |
Forrest, CR; He, W; Hopper, R; Neligan, P; Pang, CY; Xu, H; Zhong, A | 1 |
4 other study(ies) available for pyrroles and Infarct
Article | Year |
---|---|
Delayed inhibition of VEGF signaling after stroke attenuates blood-brain barrier breakdown and improves functional recovery in a comorbidity-dependent manner.
Topics: Animals; Blood-Brain Barrier; Brain; Capillaries; Dendritic Spines; Diabetes Mellitus, Experimental; Disease Models, Animal; Endothelial Cells; Gene Expression; Indoles; Infarction; Insulin; Mice; Permeability; Pyrroles; Recovery of Function; Signal Transduction; Stroke; Synapses; Transcytosis; Vascular Endothelial Growth Factor Receptor-2 | 2015 |
VEGF pathway inhibition by anticancer agent sunitinib and susceptibility to atherosclerosis plaque disruption.
Topics: Aged; Angiogenesis Inhibitors; Antineoplastic Agents; Humans; Indoles; Infarction; Intestines; Male; Plaque, Atherosclerotic; Pyrroles; Risk Factors; Sunitinib; Thromboembolism; Tomography, X-Ray Computed; Vascular Endothelial Growth Factor A | 2011 |
Pyrrole detection and the pathologic progression of Cynoglossum officinale (houndstongue) poisoning in horses.
Topics: Alkaloids; Animals; Biopsy; Cecum; Colon; Dermatitis; Edema; Horse Diseases; Horses; Infarction; Liver; Necrosis; Plants, Toxic; Poisoning; Pyrroles | 1996 |
Role of ATP-sensitive K+ channels in ischemic preconditioning of skeletal muscle against infarction.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Benzopyrans; Cromakalim; Energy Metabolism; Hypoxanthine; Infarction; Ischemic Preconditioning; Muscle, Skeletal; Phosphocreatine; Potassium Channels; Pyrroles; Reperfusion; Surgical Flaps; Swine; Vasodilator Agents; Xanthine; Xanthines | 1997 |